PHASE SCIENTIFIC
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

PHASE SCIENTIFIC Trademark

Serial Number: 87901880 • Registration: 6208297

PHASE SCIENTIFIC is a trademark filed by PHASE SCIENTIFIC INTERNATIONAL LIMITED on May 1, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

PHASE SCIENTIFIC INTERNATIONAL LIMITED (13 trademarks)

1/F, Building 22E
Shatin, N.T. , HK

Entity Type: 99

Trademark Details

Filing Date

May 1, 2018

Registration Date

December 1, 2020

Published for Opposition

September 15, 2020

Goods & Services

Assays for research purposes; Biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; Biochemical reagents used for non-medical purposes; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Biochemicals, namely, polynucleotides for in vitro and in vivo scientific and research purposes; Chemical preparations for scientific purposes; Chemical test kits for the expression, amplification, purification and analysis of biological samples for laboratory or research use; Chemicals for use in biotechnological product development; Chemicals for use in the biochemical and chemical industry; Protein in raw material form for scientific and medical research; Reagents for scientific and research use; Reagents for use in scientific apparatus for chemical or biological analysis

Medical diagnostic instruments for the analysis of body fluids; Sample preparation device for medical diagnostic uses

Medical diagnosis of human diseases, namely, genetic, infectuous, neurological, cardiovascular, cancerous, inflammatory, reproductive and developmental diseases; Medical diagnosis of ovary cancer, liver cancer, stomach cancer, pancreas cancer, esophagus cancer, colorectum cancer, lung cancer, or breast cancer; Medical diagnostic testing, monitoring and reporting services

Bio-chips for research or scientific purposes; Medical laboratory research instruments for analysis of DNA, RNA, protein and chemicals; Medical laboratory research instruments for extraction and detection of DNA, RNA, protein, chemicals and pathogens; Scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; Scientific instrumentation for measuring relative concentration of an analyte in a fluid; Scientific apparatus, namely, spectrophotometer for measuring relative DNA, RNA and protein

Consulting services for others in the field of design, planning, and implementation project management of scientific research, analysis, and testing in the field of chemistry, genetics, biology and biochemistry; Research services in the field of forensic science, namely, analysis, detection and isolation of biological substances in forensic samples; Research and development and consultation related thereto in the field of chemistry, genetics, biology and biochemistry; Scientific research and development

Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for veterinary purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, dental diseases; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, S. Mutans; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of DNA, RNA, proteins, drugs, foods, pathogens and toxins; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of cancer; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of dental diseases; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of S. Mutans; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing of body fluids; Veterinary diagnostic reagents

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Dec 1, 2025 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 16, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 16, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 16, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 16, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 16, 2023 COAR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 8, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 8, 2023 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 8, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 8, 2023 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 28, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 28, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 28, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 28, 2022 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 23, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 23, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 23, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 23, 2022 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 23, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 23, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 23, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 23, 2022 REAP
REGISTERED-PRINCIPAL REGISTER
Dec 1, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 15, 2020 NPUB
PUBLISHED FOR OPPOSITION
Sep 15, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 26, 2020 NONP
CASE RETURNED TO EXAMINATION
Aug 11, 2020 OTHE
NOTICE OF ALLOWANCE CANCELLED
Aug 10, 2020 IUCN
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Aug 10, 2020 ATRQ
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Aug 10, 2020 PCBG
TEAS RESPONSE TO PETITION INQUIRY LETTER
Aug 5, 2020 ERTI
PETITION INQUIRY LETTER ISSUED
Jul 22, 2020 PILM
ASSIGNED TO PETITION STAFF
Jul 20, 2020 APET
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 10, 2020 EXRA
SOU EXTENSION 3 GRANTED
Jun 8, 2020 EX3G
SOU EXTENSION 3 FILED
Jun 8, 2020 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 8, 2020 EEXT
TEAS PETITION TO AMEND BASIS RECEIVED
May 26, 2020 TPAD
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 7, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 7, 2020 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
May 7, 2020 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 7, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 7, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 7, 2020 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 22, 2019 EXRA
SOU EXTENSION 2 GRANTED
Nov 20, 2019 EX2G
SOU EXTENSION 2 FILED
Nov 20, 2019 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 20, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 9, 2019 EXRA
SOU EXTENSION 1 GRANTED
Mar 7, 2019 EX1G
SOU EXTENSION 1 FILED
Mar 7, 2019 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 7, 2019 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 11, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 16, 2018 NPUB
PUBLISHED FOR OPPOSITION
Oct 16, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 26, 2018 NONP
ASSIGNED TO LIE
Sep 6, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 22, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 22, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 22, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 22, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 22, 2018 CNEA
ASSIGNED TO EXAMINER
Aug 22, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 9, 2018 NWOS
NEW APPLICATION ENTERED
May 4, 2018 NWAP